Donna Gustafson (left) and her husband, Ed Gustafson. Donna had her first mRNA cancer vaccine seven years ago to treat her pancreatic cancer. Yuki Noguchi/NPR hide caption toggle caption i Yuki Noguchi/NPR Donna Gustafson is living a cancer patient’s fantasy. At 72, the retired accountant hikes, travels, lifts weights, and exchanges adoring glances with Ed,
An experimental vaccine offers new hope to patients with melanoma, one of the most aggressive forms of skin cancer. The pharmaceutical companies Merck and Moderna released the results of a Phase 3 clinical trial that evaluated the efficacy of a personalized mRNA-based vaccine that, when combined with immunotherapy, reduced the risk of disease recurrence or
Severe sunburn increases the risk of developing melanoma, the most serious type of skin cancer.Credit: Olga Pankova/Getty A personalized mRNA vaccine reduced the risk of skin cancer returning or the recipient dying by 42% when used alongside an immunotherapy drug, according to long-awaited results for what could become the first approved mRNA vaccine for cancer.
The number of influenza infections could be reduced by an mRNA vaccine.Credit: Science Photo Library On 5 August, the US Food and Drug Administration (FDA) granted approval to Moderna’s mRNA-based flu vaccine, mFLUSIVA, for adults aged 50–64, and accelerated approval for adults aged 65 and older. Moderna say it will be available “in a few
